Pancreas Transplantation Utilizing Thymoglobulin, Sirolimus, and Cyclosporine-Reference-Cited by-同舟云学术

Pancreas Transplantation Utilizing Thymoglobulin, Sirolimus, and Cyclosporine

Published:2006-04-27 Issue:8 Volume:81 Page:1101-1105
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Knight Richard J.,Kerman Ronald H.,Zela Scott,Podbielski Jeannette,Podder Hemangshu,Van Buren Charles T.,Katz Stephen,Kahan Barry D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference20 articles.

1. Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results.;Burke;Transplantation,2004

2. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation.;Kaufman;Transplantation,2002

3. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.;Stratta;Transplantation,2003

4. Pancreas transplant outcomes for United States (US) and Non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IOPTR) as of May 2003.;Gruessner,2004

5. Thymoglobulin, sirolimus and reduced dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.;Knight;Transplantation,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First World Consensus Conference on pancreas transplantation: Part II – recommendations;American Journal of Transplantation;2021-07-29

2. The science and engineering of stem cell‐derived organoids‐examples from hepatic, biliary, and pancreatic tissues;Biological Reviews;2020-10

3. Immunosuppressive Agents;Transplant Infections;2016

4. Maintenance Immunosuppressive Therapy;Textbook of Organ Transplantation;2014-07-25

5. Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective;Expert Review of Clinical Immunology;2014-01